Citigroup
CLPT icon

Citigroup’s ClearPoint Neuro CLPT Stock Holding History

Citigroup’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$188K Buy
20,617
+19,212
+1,367% +$243K ﹤0.01% 4030
2025
Q4 		$19.2K Buy
1,405
+177
+14% +$3.28K ﹤0.01% 4883
2025
Q3 		$26.8K Sell
1,228
-8,042
-87% -$94.7K ﹤0.01% 4715
2025
Q2 		$111K Buy
9,270
+8,970
+2,990% +$113K ﹤0.01% 4354
2025
Q1 		$3.57K Sell
300
-27,749
-99% -$431K ﹤0.01% 5305
2024
Q4 		$431K Sell
28,049
-62,519
-69% -$810K ﹤0.01% 3936
2024
Q3 		$1.02M Buy
90,568
+79,729
+736% +$763K ﹤0.01% 3251
2024
Q2 		$58.4K Buy
10,839
+7,003
+183% +$40.5K ﹤0.01% 4492
2024
Q1 		$26.1K Buy
3,836
+503
+15% +$3.52K ﹤0.01% 4947
2023
Q4 		$22.6K Buy
3,333
+3,292
+8,029% +$18.6K ﹤0.01% 4940
2023
Q3 		$205 Sell
41
-6,786
-99% -$40.4K ﹤0.01% 5320
2023
Q2 		$49.4K Sell
6,827
-72,718
-91% -$619K ﹤0.01% 4653
2023
Q1 		$671K Buy
79,545
+10
+0% +$88 ﹤0.01% 2886
2022
Q4 		$674K Buy
79,535
+70,423
+773% +$667K ﹤0.01% 2959
2022
Q3 		$94K Buy
9,112
+7,473
+456% +$98.5K ﹤0.01% 4118
2022
Q2 		$21K Sell
1,639
-1,495
-48% -$15.3K ﹤0.01% 4965
2022
Q1 		$33K Sell
3,134
-1,765
-36% -$16.1K ﹤0.01% 4905
2021
Q4 		$55K Buy
4,899
+2,628
+116% +$39.3K ﹤0.01% 5013
2021
Q3 		$40K Buy
2,271
+1,376
+154% +$25.8K ﹤0.01% 4859
2021
Q2 		$17K Sell
895
-13,408
-94% -$259K ﹤0.01% 5384
2021
Q1 		$302K Buy
14,303
+5,048
+55% +$108K ﹤0.01% 3776
2020
Q4 		$147K Buy
+9,255
New +$83K ﹤0.01% 5226

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Citigroup's CLPT Position: Q1 2026 in Review

Citigroup increased its ClearPoint Neuro (CLPT) stake by 1,367% in Q1 2026, buying an estimated $243K and bringing the position to 20,617 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

Citigroup first reported a position in CLPT in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.02M in Q3 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Citigroup held 20,617 shares of ClearPoint Neuro worth $188K as of Q1 2026.
  • Citigroup bought 19,212 ClearPoint Neuro shares in Q1 2026, an estimated $243K.
  • ClearPoint Neuro made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4030 holding.
  • Citigroup first reported a position in ClearPoint Neuro in Q4 2020 and has held it in 22 quarters since.
  • Citigroup's ClearPoint Neuro position peaked at $1.02M in Q3 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.